Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

casimersen

casimersen
  • Non-formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Amondys-45 INJECTION, INTRAVENOUS 50 mg/mL      
Comments:

Defer initiation to non-hospital related outpatient setting, Rare need is expected. If patient identified, a patient specific prescription through a specialty pharmacy would be required.

Reviewed: June 2023 (Amondys-45)

Spotlight Casimersen (Amondys-45)

Last updated: Aug. 28, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved